Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Marchetti

Showing results (291-300 of 450) with videos related to

Pageof 45
Sort By:
The Breast Journal|December 19, 2007
Timed-flat infusion of 5-fluorouracil associated with docetaxel as first-line treatment of patients with metastatic breast cancerAnna Iolanda Rispoli, Maria Francesca Morelli, Enrico Ricevuto, et al.
Frontiers in Oncology|January 30, 2023
The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities managementMichela Roberto, Martina Panebianco, Anna Maria Aschelter, et al.
BMC Cancer|June 8, 2012
Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI studyMatteo Clavarezza, Giorgio Mustacchi, Andrea Casadei Gardini, et al.
Journal of Personalized Medicine|November 7, 2020
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC PatientsIlaria Grazia Zizzari, Alessandra Di Filippo, Fabio Scirocchi, et al.
Clinical Colorectal Cancer|April 2, 2018
Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program StudyAlessandro Pastorino, Maria Di Bartolomeo, Evaristo Maiello, et al.
Dermatology Reports|September 9, 2021
Integrated care pathways and the hub-and-spoke model for the management of non-melanoma skin cancer: A proposal of the Italian Association of Hospital Dermatologists (ADOI)Luca Fania, Cesare Massone, Francesco Cusano, et al.
European Journal of Human Genetics : EJHG|September 2, 2004
Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutationsFabio Marroni, Paolo Aretini, Emma D'Andrea, et al.
Journal of Translational Medicine|February 5, 2020
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatmentAndrea Botticelli, Pamela Vernocchi, Federico Marini, et al.
Human Vaccines & Immunotherapeutics|March 8, 2022
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory studyErnesto Rossi, Ilaria Grazia Zizzari, Alessandra Di Filippo, et al.
Journal of Translational Medicine|March 24, 2021
The role of opioids in cancer response to immunotherapyAndrea Botticelli, Alessio Cirillo, Giulia Pomati, et al.
Pageof 45

Showing results (291-300 of 450) with videos related to

Sort By:
Pageof 45
The Breast Journal|December 19, 2007
Timed-flat infusion of 5-fluorouracil associated with docetaxel as first-line treatment of patients with metastatic breast cancerAnna Iolanda Rispoli, Maria Francesca Morelli, Enrico Ricevuto, et al.
Frontiers in Oncology|January 30, 2023
The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities managementMichela Roberto, Martina Panebianco, Anna Maria Aschelter, et al.
BMC Cancer|June 8, 2012
Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI studyMatteo Clavarezza, Giorgio Mustacchi, Andrea Casadei Gardini, et al.
Journal of Personalized Medicine|November 7, 2020
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC PatientsIlaria Grazia Zizzari, Alessandra Di Filippo, Fabio Scirocchi, et al.
Clinical Colorectal Cancer|April 2, 2018
Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program StudyAlessandro Pastorino, Maria Di Bartolomeo, Evaristo Maiello, et al.
Dermatology Reports|September 9, 2021
Integrated care pathways and the hub-and-spoke model for the management of non-melanoma skin cancer: A proposal of the Italian Association of Hospital Dermatologists (ADOI)Luca Fania, Cesare Massone, Francesco Cusano, et al.
European Journal of Human Genetics : EJHG|September 2, 2004
Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutationsFabio Marroni, Paolo Aretini, Emma D'Andrea, et al.
Journal of Translational Medicine|February 5, 2020
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatmentAndrea Botticelli, Pamela Vernocchi, Federico Marini, et al.
Human Vaccines & Immunotherapeutics|March 8, 2022
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory studyErnesto Rossi, Ilaria Grazia Zizzari, Alessandra Di Filippo, et al.
Journal of Translational Medicine|March 24, 2021
The role of opioids in cancer response to immunotherapyAndrea Botticelli, Alessio Cirillo, Giulia Pomati, et al.
Pageof 45